BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mohan V, Wangnoo S, Das S, Dhediya R, Gaurav K. Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review. World J Diabetes 2022; 13(12): 1168-1183 [PMID: 36578872 DOI: 10.4239/wjd.v13.i12.1168]
URL: https://www.wjgnet.com/1948-9358/full/v13/i12/1168.htm
Number Citing Articles
1
Rifika Bansal, Ravi Kant, Yogesh Bahurupi, Ashwarya Gupta. Efficacy and Safety of Gliclazide versus Glimepiride in T2DM Patients: A Systematic ReviewIndian Journal of Endocrinology and Metabolism 2025; 29(3): 260 doi: 10.4103/ijem.ijem_372_24